Infliximab Extends the Duration until the First Surgery in Patients with Crohn’s Disease

<table>The results of a univariate analysis of the cumulative nonoperative rate based on the presence or absence of infliximab treatment. The univariate analysis revealed that the administration of infliximab is a factor estimated to improve the cumulative nonoperative rate.</table>

BioMed Research International

fig2

Figure 2

Figure 2: Infliximab Extends the Duration until the First Surgery in Patients with Crohn’s Disease 